Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vivos Therapeutics, Inc. (VVOS)
:VVOS
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
VVOS Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Alliance Global Partners
$8.25→$6
Buy
81.27%
Upside
Reiterated
11/19/24
Vivos Therapeutics price target lowered to $6 from $8.25 at Alliance Global PartnersVivos Therapeutics price target lowered to $6 from $8.25 at Alliance Global Partners
Ascendiant
$6.6
Buy
99.40%
Upside
Reiterated
11/19/24
We are raising our FY24 EPS estimates to $(1.79) from $(3.13) on lower costs and higher share count. We are trimming our FY24 revenue estimate to $15.2 million from $16.3 million. We are raising our FY25 estimate to $(1.43), from $(2.47) previously, on revenues of $18.3 million, versus $19.2 million previously. Consensus estimates are $(3.13) and $(2.47) on revenues of $16.3 million and $19.2 million for FY24 and FY25, respectively. FDA approves use of Vivos CARE appliances to treat moderate to severe OSA in children: Vivos announced receipt of FDA 510(k) clearance to treat moderate to severe sleep apnea in children, a first in the industry. The clearance complements approval granted in November 2023 for use of Vivos’ flagship CARE appliances to treat severe OSA in adults. Both are welcome validations of Vivos’ non-surgical approach to curing OSA.
Best Analysts Covering Vivos Therapeutics
Which Analyst Should I Follow If I Want to Buy VVOS and Sell After:
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+18.47%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +18.47% per trade.
3 Months
xxx
Success Rate
4/7 ratings generated profit
Average Return
+10.74%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +10.74% per trade.
1 Year
Success Rate
4/7 ratings generated profit
Average Return
+2.40%
reiterated a buy rating 3 months ago
Copying Lucas Ward's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.40% per trade.
2 Years
xxx
Success Rate
5/7 ratings generated profit
Average Return
+10.33%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +10.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VVOS Analyst Recommendation Trends
Rating
Feb 24
Apr 24
May 24
Aug 24
Nov 24
Strong Buy
2
2
3
3
4
Buy
1
1
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
4
Each month's total comprises the sum of three months' worth of ratings.
VVOS Stock Forecast FAQ
What is VVOS’s average 12-month price target, according to analysts?
Based on analyst ratings, Vivos Therapeutics, Inc.’s 12-month average price target is $6.30.
What is VVOS’s upside potential, based on the analysts’ average price target?
Vivos Therapeutics, Inc. has 90.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VVOS a Buy, Sell or Hold?
Vivos Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Vivos Therapeutics, Inc.’s price target?
The average price target for Vivos Therapeutics, Inc. is $6.30. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.60 ,the lowest forecast is $6.00. The average price target represents 90.33% Increase from the current price of $3.31.
The highest analyst price target is $6.60 ,the lowest forecast is $6.00. The average price target represents 90.33% Increase from the current price of $3.31.
What do analysts say about Vivos Therapeutics, Inc.?
Vivos Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of VVOS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.